Biogen Pharmachem Industries Ltd
company logo

Biogen Pharmachem Industries Ltd

Finance
Small Cap

-

0 (0%)

Biogen Pharmachem Industries Ltd Performance

-

-

-

-


-

-

-

-

-

Biogen Pharmachem Industries Ltd Fundamentals

97.89Cr

50

1.73

0

0.03

0%

0.87

i buttonClick here to know more about Fundamentals

Biogen Pharmachem Industries Ltd Financials

Biogen Pharmachem Industries Ltd Financialsright-arrow

Biogen Pharmachem Industries Ltd Shareholding Pattern

Biogen Pharmachem Industries Ltd Delivery and Volume

About Biogen Pharmachem Industries Ltd

Biogen Pharmachem Industries Ltd was formerly incorporated as Wellworth Overseas Limited in July, 1995. The name of the Company was changed to Sun Techno Overseas Limited in August 2011 and again the name got changed from Sun Techno Overseas Limited to Biogen Pharmachem Industries Limited on March 2

-

1995

-

NameDesignation
Niraj VaghelaChairman & WTD & CFO
Chandrakant Govingbhai ParmarIndependent Director
Khushboo KhandelwalCompany Sec. & Compli. Officer
Harshadkumar RathodDirector
Narendrakumar VaniyaDirector
Komalben ChauhanDirector
CHHAYA PARMARNon Executive Director
News and Events...

Similar Stocks

What's Trending

Biogen Pharmachem Industries Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Biogen Pharmachem Industries Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Biogen Pharmachem Industries Ltd's share price is ₹1.5 as of 2024-07-27.
Biogen Pharmachem Industries Ltd's P/E ratio is 50 times as of 2024-07-27.
Biogen Pharmachem Industries Ltd's most recent financial reports indicate a price-to-book ratio of 1.73, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Biogen Pharmachem Industries Ltd's market capitalization is ₹97.89 Cr as on 2024-07-27.
The current financial records of Biogen Pharmachem Industries Ltd show a -0.34% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Biogen Pharmachem Industries Ltd's most recent financial filings, the company has a total asset value of ₹0.15, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Biogen Pharmachem Industries Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Biogen Pharmachem Industries Ltd's 52-week high and low as of 2024-07-27 are ₹1.54 and ₹1.45, respectively.